Literature DB >> 10188914

Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma.

W Tschugguel1, T Pustelnik, H Lass, M Mildner, W Weninger, C Schneeberger, B Jansen, E Tschachler, T Waldhör, J C Huber, H Pehamberger.   

Abstract

Expression of inducible nitric oxide synthase (iNOS) and its cellular localization was investigated in subcutaneous or lymph node metastases of human melanoma. Immunohistochemistry revealed that iNOS expression was limited to melanoma cells. In samples of patients without distant metastases, the number of iNOS+ tumour cells/total tumour cells was 55% +/- 17% (n = 12) compared with 9% +/- 8% when distant metastases of lung, liver or brain occurred within an observation period of 3 years (n = 10) (P < 0.001). Western blotting confirmed the expression of iNOS protein in select cases. Notably, iNOS is expressed in regional melanoma metastases and its expression is inversely related to the tumour's metastatic potential. Thus, iNOS expression may have predictive value for the development of distant metastases of human melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188914      PMCID: PMC2362722          DOI: 10.1038/sj.bjc.6690256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  Activation of nitric oxide synthase gene for inhibition of cancer metastasis.

Authors:  K Xie; Z Dong; I J Fidler
Journal:  J Leukoc Biol       Date:  1996-06       Impact factor: 4.962

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 3.  Regulation of biosynthesis of nitric oxide.

Authors:  C Nathan; Q W Xie
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

Review 4.  NO at work.

Authors:  H H Schmidt; U Walter
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

5.  Nitric oxide synthase activity in human gynecological cancer.

Authors:  L L Thomsen; F G Lawton; R G Knowles; J E Beesley; V Riveros-Moreno; S Moncada
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

6.  CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.

Authors:  J Pammer; A Plettenberg; W Weninger; B Diller; M Mildner; A Uthman; W Issing; M Stürzl; E Tschachler
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

7.  Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells.

Authors:  Z Dong; A H Staroselsky; X Qi; K Xie; I J Fidler
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

8.  p53 expression in nitric oxide-induced apoptosis.

Authors:  U K Messmer; M Ankarcrona; P Nicotera; B Brüne
Journal:  FEBS Lett       Date:  1994-11-21       Impact factor: 4.124

9.  Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells.

Authors:  K Xie; S Huang; Z Dong; S H Juang; M Gutman; Q W Xie; C Nathan; I J Fidler
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  6 in total

1.  Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion.

Authors:  Huiwen Cheng; Molly Y Mollica; Shin Hee Lee; Lei Wang; Carlos A Velázquez-Martínez; Shiyong Wu
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-04       Impact factor: 4.219

2.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

Review 3.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

4.  Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma.

Authors:  Zhen Yang; Bobbye Misner; Haitao Ji; Thomas L Poulos; Richard B Silverman; Frank L Meyskens; Sun Yang
Journal:  Antioxid Redox Signal       Date:  2013-01-18       Impact factor: 8.401

Review 5.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

6.  Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.

Authors:  Hicham H Baydoun; Mathew A Cherian; Patrick Green; Lee Ratner
Journal:  Retrovirology       Date:  2015-08-12       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.